David Lickorish
Director, Us Medical Publications @Takeda
Signup · Get unlimited contacts
WORK HISTORY
Director, Us Medical Publications @Takeda
Lexington, MA, US
EDUCATION
UNSW
PhD, Pathology
UNSW
B. Adv.Sc. (Hons), Anatomy/Pathology
SKILLS
ABOUT DAVID LICKORISH
Cell and gene therapy focused medical affairs professional experienced in the strategic and tactical delivery of GPP 2022 compliant, scientific content spanning full lifecycle development. Medical communication and publications expertise includes:1) The first US/EU approved AAV-based GT for Hemophilia B (Hemgenix - etranacogene dezaparvovec)2) The first approved CRISPR/Cas9-based autologous stem cell therapy for SCD in the UK and US (Casgevy - exagamglogene autotemcel). Medical writer and scientist with >15yrs experience in rare disease preclinical/clinical research within academia and industry involving biomaterials, pain, tissue engineering, recombinant growth factors, and human umbilical cord derived mesenchymal stem cells (US patent underpins research product licensed to RoosterBio).Opinions expressed are my own.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.